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Stress Echocardiography to Assess Stenosis
Severity and Predict Outcome in Patients With
Paradoxical Low-Flow, Low-Gradient Aortic
Stenosis and Preserved LVEF
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The objective of this studywas to examine the value of stress-echocardiography in patients with paradox-
ical low-flow, low-gradient (PLFLG) aortic stenosis (AS). Theprojectedaortic valve area (AVAProj) at anormal
flow ratewas calculated in 55 patientswith PLFLGAS. In the subset of patients (n 13)who underwent an
aortic valve replacementwithin 3months after stress echocardiography, AVAProj correlatedbetterwith the
valve weight compared to traditional resting and stress echocardiographic parameters of AS severity
(AVAProj: r0.78 vs. other parameters: r 0.46 to 0.56). In the whole group (N 55), 18 (33%) patients
ad an AVAProj1.0 cm
2, being consistent with the presence of pseudo severe AS. The AVAProj was also
superior to traditional parameters of stenosis severity for predicting outcomes (hazard ratio: 1.32/0.1 cm2
decrease in AVAProj). In patients with PLFLG AS, the measurement of AVAproj derived from stress echocar-
iography is helpful to determine the actual severity of the stenosis and predict risk of adverse
vents. (J AmColl Cardiol Img2013;6:175–83)©2013by theAmericanCollegeofCardiology Foundationde
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176despite the presence of a preserved LV ejection
fraction (i.e., LVEF 50%), and this clinical entity
as labeled “paradoxical low-flow, low-gradient
PLFLG) AS” (1,2). Given that transvalvular flow
ate is reduced in these patients, it cannot be
xcluded that, as in low LVEF, low-flow, low-
radient AS, some patients may have a pseudo
evere AS due to incomplete opening of a moder-
tely stenotic valve.
The distinction between true severe (TS) versus
pseudo severe (PS) AS is essential because patients
with TS AS and symptoms will generally benefit
from aortic valve replacement (AVR), whereas pa-
tients with PS AS may not benefit from surgical
intervention and may rather need intensive medical
therapy and close follow-up. As recommended in
the 2012 European Society of Cardiology/
European Association for Cardiothoracic
Surgery guidelines, AVR should be con-
sidered in symptomatic patients with PL-
FLG after careful confirmation of stenosis
severity (Class IIa indication) (3). We
previously reported that a new index of AS
severity derived from dobutamine stress
echocardiography (DSE), the projected
aortic valve area (AVAproj) at a normal
transvalvular flow rate, is superior to tra-
ditional Doppler echocardiographic pa-
rameters (rest or peak stress gradient and
AVA) to differentiate TS from PS AS and
predict outcome in patients with low
LVEF, low-flow, low-gradient AS (4).
However, there are no published data
about the utility of stress (dobutamine or
exercise) echocardiography in patients
with PLFLG AS. The objective of this
study was to examine the diagnostic and
rognostic value of stress echocardiography in
atients with PLFLG AS.
Methods
Doppler echocardiographic and clinical data were
prospectively collected in 55 patients with PLFLG
AS defined as an AVA 1 cm2, an indexed AVA
0.6 cm2/m2, a mean gradient 40 mm Hg, a
reserved LVEF (50%), and stroke volume indexed
o body surface area 35 ml/m2. These patients were
ecruited in the context of 2 prospective observational
tudies, TOPAS (True Or Pseudo-Severe Aortic Steno-
is) and EXERSA (Exercise Stress Echocardiography in
ortic Stenosis) (4,5). Exclusion criteria for these studies
alve
ent
ion
were as follows: 1) moderate/severe aortic or mitralegurgitation or mitral stenosis; 2) atrial fibrillation or
utter; 3) paced rhythm; 4) unstable angina; 5) acute
ulmonary edema; 6) end-stage renal disease; 7) preg-
ant or lactating women; and 8) unwillingness to provide
nformed consent.
All patients underwent stress echocardiography.
xercise stress echocardiography was performed in
7 patients with no or equivocal symptoms whereas
SE was performed in 18 patients who were
ymptomatic. The dobutamine infusion protocol con-
isted of 8-min increments of 2.5 or 5 g/kg/min,
starting at 2.5 g/kg/min up to a maximum dosage
of 20 g/kg/min (4). The exercise test was a
symptom-limited graded maximum bicycle exercise
test, performed in the semisupine position on an
ergometer table tilted to 20°, with an initial work-
load of 20 W to 25 W maintained for 3 min and
subsequent increase in workload of 20 W to 25 W
every 3 min (5). Doppler echocardiographic data were
obtained at rest and at peak exercise/dobutamine stress.
The Doppler echocardiographic measurements
included LV dimensions, LVEF determined by the
modified biplane Simpson’s method, stroke volume
in the LV outflow tract, mean transvalvular flow
rate (Q) by dividing stroke volume by LV ejection
time, transvalvular gradients by the simplified Ber-
noulli equation, and AVA by the continuity equation.
The LV outflow tract diameter was assumed to have
remained constant during the stress test protocol. For
each measurement, at least 3 cardiac cycles were
averaged. The projected AVA (AVAproj) was calcu-
ated, a posteriori, in each patient by the following
quation, as previously described and validated (4):
AVAproj
AVApeakAVArest
QpeakQrest
 250QrestAVArest
where AVArest and Qrest are AVA and Q at rest,
nd AVApeak and Qpeak are AVA and Q measured
t peak stress echocardiography. The treating car-
iologists and cardiac surgeons were thus unaware
f the results of AVAProj.
The endpoints for this study were as follows.
1) The severity of stenosis at the time of AVR as
documented by macroscopic assessment of the ex-
planted valve by the surgeon and pathologist with the use
of standardized method and criteria (4); the weight of
explanted valve was also measured with the use of a
laboratory scale in a subset of patients. 2) The time to
occurrence of the composite endpoint of death or need
for AVR motivated by the development of severe ASA B B R E V I A T I O N S
A N D A C R O N YM S
AS aortic stenosis
AVA aortic valve area
AVAProj projected aortic v
rea
VR aortic valve replacem
I confidence interval
SE dobutamine stress
chocardiography
R hazard ratio
V left ventricular
VEF left ventricular eject
raction
LFLG paradoxical low flo
ow gradient
S pseudo severewith symptoms or LV systolic dysfunction.
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177Results are expressed as mean SD or percentages.
Continuous variables were tested for distribution nor-
mality with the Shapiro-Wilk test. Differences be-
tween patient groups were analyzed with the use of the
2-sided Student t test for continuous variables and the
chi-square test or Fisher exact test for categorical
variables as appropriate. Sensitivity, specificity, and
percentage of correct classification for the prediction
of TS AS were determined for various cutoff values of
the Doppler echocardiographic indices of stenosis
severity using receiver-operating characteristic curves.
Correlation between stenotic indices and valve weight
was determined with the use of Pearson correlation.
Differences between correlation coefficients were ana-
lyzed with the use of the Wolfe test.
Event-free survival function was obtained by
Kaplan-Meier estimates. The effect of the clinical
Table 1. Baseline Patient Characteristics
Variable
Clinical data
Age, yrs
Male
Body surface area, m2
Symptoms
Systolic blood pressure, mm Hg
Diastolic blood pressure, mm Hg
Hypertension
Obesity
Diabetes mellitus
Dyslipidemia
Chronic kidney disease
Doppler echocardiographic data
Aortic valve morphology (bicuspid/tricuspid/unevaluable)
LVEF, %
Peak SE LVEF, %
SV index, ml/m2
Peak SE SV index, ml/m2
∆ SV index, ml/m2
Rest ﬂow rate, ml/s
Peak SE ﬂow rate, ml/s
∆ Flow rate, ml/s
Rest mean gradient, mm Hg
Peak SE mean gradient, mm Hg
Rest AVA, cm2
Peak SE AVA, cm2
AVAproj, cm
2
Indexed AVAproj, cm
2/m2
Rest Zva, mm Hg·ml
1·m2
Peak SE Zva, mm Hg·ml
1
Values are mean  SD or n (%). Delta (∆) indicates absolute difference betwee
AVA  aortic valve area; AVAProj  projected aortic valve area; AVR echocardiography; SV  stroke volume; Zva  valvuloarterial impedance.and Doppler echocardiographic variables on sur-
vival was assessed with the use of Cox proportional
hazard models. A p value 0.05 was considered
statistically significant. Statistical analyses were per-
formed with the use of JMP 8.0.1 software (SAS
Institute, Cary, North Carolina).
Results
Our population consisted of 35 (64%) men and 20
(36%) women with a mean age of 65  13 years;
prevalence of hypertension was 55%, diabetes mel-
litus, 18%, and chronic kidney disease, 11%. The
average AVA was 0.83  0.17 cm2, and average
ean gradient 27  16 mm Hg (Table 1). During
mean follow-up of 1.5  1.4 years, 27 (49%)
atients underwent an AVR for symptomatic severe
le Cohort
 55)
No Event
(n  24)
AVR or Death
(n  31) p Value
5 13 64 15 66 11 0.44
35 (64) 14 (58) 21 (68) 0.47
4 0.24 1.82 0.26 1.85 0.23 0.60
18 (33) 9 (38) 9 (29) 0.51
9 24 132 22 145 25 0.06
9 14 76 10 81 16 0.23
30 (55) 15 (63) 15 (48) 0.30
14 (25) 7 (29) 7 (23) 0.58
10 (18) 6 (25) 4 (13) 0.25
32 (58) 17 (71) 15 (48) 0.09
6 (11) 1 (4) 5 (16) 0.14
7/36/2 9/15/0 8/21/2 0.44
2 7 61 7 62 7 0.84
2 10 72 8 73 11 0.67
2 3 32 3 32 3 0.80
9 10 39 7 39 11 0.98
7 8 7 7 6 10 0.86
7 46 195 32 198 29 0.78
9 84 281 83 295 86 0.57
2 78 86 74 96 82 0.95
7 16 23 11 28 10 0.08
0 16 33 15 45 15 0.006
3 0.17 0.88 0.21 0.80 0.17 0.13
1 0.32 1.09 0.36 0.94 0.27 0.07
5 0.24 1.04 0.24 0.88 0.22 0.01
3 0.15 0.59 0.16 0.48 0.12 0.007
.1 1.1 4.8 0.9 5.4 1.0 0.05
.7 1.9 5.0 1.3 6.1 2.1 0.04
ak stress and rest data.
valve replacement; LVEF  left ventricular ejection fraction; SE  stressWho
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178AS, and 4 (7%) patients died: 1 had a sudden
cardiac death, 1 died of acute pulmonary edema, 1
died of end-stage heart failure, and 1 died of
noncardiovascular cause.
Among the 37 patients who underwent exercise
stress echocardiography, the maximum workload
achieved by the patients was 119 94 W (range 44
o 480 W). Among the 18 patients who underwent
True-Severe AS at AVR
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AS severity not verified by A
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Figure 1. Accuracy of Stress Echocardiographic Parameters to D
(A) Projected aortic valve area (AVAProj) at normal ﬂow rate. (B) IndSE, the dose of dobutamine at termination oftress test was 20 g/kg/min in 7 patients, 15
g/kg/min in 4 patients, and 10 g/kg/min in 7
atients. No adverse effects occurred during stress
chocardiography, and all patients had an increase
n mean transvalvular flow rate 15% (range 30
o 274 ml/s; i.e., 17% to 157%), thus allowing the
alculation of AVAproj (4).
Among the 27 patients treated surgically, 16
Pseudo-severe AS on the basis of
AVA proj>1cm2
(33%)
Patients who underwent AVR
within 3 months after Stress echo
True-severe AS on the basis of
AVA proj   1cm2
(67%)
≤
Pseudo-severe AS on the basis of
Index AVA proj >0.55 cm2/m2
(35%)
Patients who underwent AVR
within 3 months after Stress echo
True-severe AS on the basis of
Index AVA proj    0.55 cm2/m2
(65%)
≤
rentiate True Severe From Pseudo Severe Aortic Stenosis
AVAProj at normal ﬂow rate.VR
VR
iffehad an AVR within the 3 months after stress
A
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179echocardiography. The valves explanted from
these 16 patients were evaluated for AS severity
by the cardiac surgeon and the pathologist, and
13 of them were weighted.
Among the 16 explanted valves, 13 (81%) were
considered as TS AS, and 3 (19%) as PS AS.
Among the stress Doppler echocardiographic pa-
rameters of stenosis severity, AVAproj or indexed
VAproj had the best accuracy to differentiate TS
True-Severe AS at AVR
Pseudo-Severe AS at AVR
AS severity not verified by AVR
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Figure 1. Continued
(C) Peak stress AVA. (D) Peak stress gradient. AS  aortic stenosis;
echocardiography; MG  mean gradient.ersus PS AS in this subset (Fig. 1). An AVAproj1 cm2 was the best cutoff value to predict TS AS
with an area under the receiver-operating charac-
teristic curve of 0.99, a sensitivity of 92%, a speci-
ficity of 100%, and a percentage of correct classifi-
cation of 94% (Fig. 1). The best cutoff for indexed
AVAproj was 0.55 cm
2/m2 (sensitivity of 100%,
pecificity of 67%, and percentage of correct classi-
cation of 88%). Moreover, AVAproj or indexed
AVAproj correlated better (Wolfe p values 0.05)
Pseudo-severe AS
on the basis of
AVA >1.0 cm2
(49%)
tients who underwent AVR
thin 3 months after Stress echo
True-severe AS
on the basis of
AVA   1.0 cm2
(51%)
Pseudo-severe AS
on the basis
of AVA >1.2 cm2
(24%)
True-severe AS
on the basis
of AVA   1.2 cm2
(76%)
True-severe AS
on the basis of
MG   30 mm Hg
(71%)
tients who underwent AVR
hin 3 months after Stress echo
Pseudo-severe AS
on the basis of
MG < 30 mm Hg
(29%)
True-severe AS
on the basis of
MG   40 mm Hg
(42%)
Pseudo-severe AS
on the basis of
MG < 40 mm Hg
(58%)
 aortic valve replacement; CC  correct classiﬁcation; echo Pa
wi
Pa
wit
AVRwith the weight of the explanted valve (r  0.78;
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180p  0.002) (Fig. 2) compared to the traditional
stress echocardiographic indices of stenosis severity
(r 0.56; p0.05). In the whole study group (n
55), 18 (33%) patients had an AVAproj 1.0 cm
2,
and 19 (35%) had an indexed AVAproj 0.55
cm2/m2, which is consistent with the presence of PS
AS (Figs. 1A and 1B).
The AVAproj (hazard ratio [HR]: 1.25/0.1 cm
2
decrease in AVAproj; 95% confidence interval [CI]:
.06 to 1.48; p 0.008) and indexed AVAproj (HR:
.55/0.1 cm2/cm2 decrease in indexed AVAproj;
95% CI: 1.16 to 2.12; p  0.002) predicted the risk
of events, whereas the other stress echocardio-
graphic parameters generally used to differentiate
TS versus PS AS did not (Table 2, Fig. 3). After
adjustment for age and sex, lower AVAproj (HR:
1.32/0.1 cm2 decrease in AVAproj; 95% CI: 1.10 to
.60; p  0.002) or lower indexed AVAproj
(HR: 1.59/0.1 cm2 decrease in indexed AVAproj;
5% CI: 1.18 to 2.22; p  0.002) remained predic-
ors of higher risk of events (Table 2, Fig. 3).
Discussion
The main finding of this study is that the measure-
r = -0.78
p = 0.002
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Figure 2. Correlation Between Stress Echocardiographic Parame
Replacement Surgery
(A) Projected aortic valve area (AVA) at normal ﬂow rate. (B) Indexe
(D) Peak stress gradient.ment of AVAproj by stress echocardiography allowsaccurate discrimination of TS versus PS AS in
patients with PLFLG AS. On this basis, this study
revealed that approximately 30% of these patients
have a PS AS, which is consistent with what has
been reported in patients with classical (i.e., low-
LVEF) low-flow, low-gradient AS (4). Although
they have preserved LVEF, patients with paradox-
ical low-flow have transvalvular flow rates that are
as low as patients with low-LVEF, low-flow, low
gradient AS (4). That likely explains why the
prevalence of PS AS is similar in patients with
paradoxical low-flow AS versus patients with clas-
sical low-flow AS.
Low-flow, low-gradient AS is a highly challeng-
ing condition in terms of diagnosis and therapeutic
management. The presence of a low-flow state in
the setting of a preserved LVEF may considerably
complicate assessment of stenosis severity and ther-
apeutic decision making. Indeed, although these
patients with paradoxical low-flow, low-gradient of-
ten have similar or worse AVA at rest compared to
patients with normal flow, their gradient is much
lower than expected because of the low flow across the
valve. The clinical presentation of these patients may
r = -0.56
p = 0.05
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181“pseudonormalized” gradient, the stenosis severity
may be underestimated. Conversely, as in patients
with low-LVEF, low-flow, low-gradient AS, the
AVA may overestimate stenosis severity in some
patients because of the low flow.
Several studies have demonstrated the usefulness
of the measurement of the gradient and AVA
during a low-dose DSE to corroborate stenosis
severity in patients with classical low-flow, low-
gradient AS and reduced LVEF. The major limi-
tation of the peak stress gradient or AVA is that they
are dependent on flow rate, which may vary exten-
sively from one patient to another (4). We have
previously reported that AVAproj can mitigate for
important interindividual variability in transvalvular
flow response during DSE, and result in improved
diagnostic accuracy compared to traditional DSE
parameters for distinguishing TS from PS AS in
patients with classical low-flow, low-gradient AS and
reduced LVEF (4). In the present study, we demon-
strate, for the first time to our knowledge, that the
AVAproj measured by stress echocardiography with
he use of the simplified method (4) is superior to
ther traditional stress echocardiographic parameters
peak stress gradient and AVA) to identify TS AS and
redict outcomes in patients with paradoxical low-
ow AS.
The explanation for this superiority of the
VAproj may be that, as opposed to all other
Table 2. Predictors of Combined Endpoint Aortic Valve Replace
Increment Category
Univ
Variables HR (95%
Age 1 yr 1.02 (0.99
Sex Male 1.36 (0.64
Diabetes mellitus Yes 1.62 (0.46
Chronic kidney failure Yes 2.35 (0.79
Rest LVEF 5% 0.99 (0.77
Peak SE LVEF 5% 1.02 (0.86
∆ LVEF 5% 1.03 (0.84
Rest SV Index 1 ml/m2 1.03 (0.94
Peak SE SV Index 1 ml/m2 1.02 (0.97
∆ SV Index 1 ml/m2 1.02 (0.96
Rest mean gradient 5 mmHg 1.13 (0.99
Peak SE mean gradient 5 mmHg 1.13 (1.03
Rest AVA 0.1 cm2 1.12 (0.95
Peak SE AVA 0.1 cm2 1.08 (0.96
AVAProj 0.1 cm
2 1.25 (1.06
Indexed AVAProj 0.1 cm
2/m2 1.55 (1.16
Delta (∆) indicates absolute difference between peak stress and rest data.
CI  conﬁdence interval; HR  hazard ratio; other abbreviations as in Table 1tenotic indices, AVAproj is standardized for flowate. This is an important advantage given that flow
ate may vary considerably from one patient to
nother during stress echocardiography. Indeed,
atients with reduced or preserved LVEF low-flow
S may not reach the normal range of resting flow
ate under stress echocardiography, and as a conse-
uence, their peak stress gradient may remain below
0 mm Hg although the valve is severely stenotic or
heir peak stress AVA may remain below 1.0 cm2
although their stenosis is only moderate. Con-
versely, the flow rate may exceed the normal resting
values, so that the peak stress gradient may increase
above 40 mm Hg despite the presence of a moder-
ate stenosis. The AVAproj may be helpful to recon-
cile these discordances and better assess the true
severity of the stenosis.
Although DSE was well tolerated in the patients
included in this study, this test should be used with
caution, using a low-dose protocol with progressive
increase in dosage and close monitoring of blood
pressure, electrocardiogram, and LV outflow tract
velocity. Patients with paradoxical low-flow AS
indeed often have a pronounced LV concentric
remodeling with small cavity and impaired LV
filling, and thus, they may be at risk for deteriora-
tion of hemodynamic status under dobutamine
stress. The feasibility and safety of DSE and exer-
cise stress echocardiography will need to be evalu-
ated in a larger series of patients with PLFLG AS.
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182feasible or inconclusive, one may envision other
imaging modalities such as quantification of aortic
valve calcification by multislice computed tomogra-
phy (CT) to confirm stenosis severity in these
patients. Computed tomography has been shown to
accurately differentiate TS from PS AS in patients
with classical low-flow AS (6). Further studies are
needed to assess the usefulness of CT calcium
scoring in the subset of patients with paradoxical
low-flow AS. Patients with PLFLG AS with evi-
dence of TS AS at stress echocardiography or CT
should undergo AVR or transcatheter aortic valve
implantation. Several studies have reported that
patients with PLFLG AS have worse outcomes
AVAproj >1cm2
AVAproj  ≤ 1cm2
HR = 1.25; p = 0.008
HR*= 1.32; p = 0.002
Follow-up Time, Months
0 6 12 18 24
37 22 19 13 9
18 17 14 11 7
Indexed AVAproj > 0.55  cm2/m2
Indexed AVAproj ≤ 0.55 cm2/m2
HR = 1.55; p = 0.002
HR*= 1.59; p = 0.002
Follow-up Time, Months
0 6 12 18 24
36 21 18 13 9
19 18 15 11 7
Event-Free Survival According to AVAProj
survival according to (A) projected aortic valve area (AVAProj) at
w rate and (B) indexed AVAproj during stress echocardiography.
tio (HR) adjusted for age and sex.gradient AS (2), and that AVR improves survival in
these patients (1).
The presence of PS AS should not necessarily be
interpreted as equivalent to mild disease and good
prognosis. These patients often have moderate AS
plus moderate/severe hypertension, which impose a
high hemodynamic burden on the left ventricle.
That may in turn worsen the LV concentric
remodeling, the myocardial fibrosis, the impairment
of diastolic filling, and pump function. Optimiza-
tion of antihypertensive therapy and close monitor-
ing of valve hemodynamic and LV function should
be considered in these patients. Also, it should be
kept in mind that failure of medical therapy could
also be due to a worsening of AS severity during
follow-up, in which case AVR should be reconsid-
ered. Further studies are needed to establish what
is the most appropriate therapeutic management
for patients with PLFLG AS having evidence of
PS AS.
Study limitations. The most important limitation of
this study is the small number of patients, and
further studies in larger number of patients are
needed to confirm the utility of AVAproj to confirm
stenosis severity in PLFLG AS. Nevertheless, this
is the first study, to our knowledge, to establish the
feasibility, safety, and utility of stress echocardiog-
raphy in the context of patients with PLFLG AS.
Interestingly, the results that we found in this
subset of patients were highly consistent with those
that we previously reported in patients with classical
low-flow, low-gradient AS (4).
Conclusions
This study reports that AVAproj measured by stress
chocardiography better predicts the actual stenosis
everity and clinical outcome of patients with PL-
LG AS. Thus, AVAproj may help in therapeutic
decision making in this challenging group of pa-
tients by providing a more accurate surgical indica-
tion. The risk-benefit ratio of stress echocardiogra-
phy in this context, however, needs to be better
established in larger series of patients before it can
be advocated for routine clinical utilization.
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